By Tehelka Web Desk
In a move expected to benefit thousands of patients suffering from diabetes and other chronic illnesses, the government has fixed retail prices for several essential medicines, making treatment more affordable across Jammu and Kashmir and the rest of the country.
The decision was taken by the National Pharmaceutical Pricing Authority (NPPA), which recently capped the prices of 30 drug formulations used for the treatment of diabetes, hypertension, heart disease and other health conditions.
The move comes at a time when the burden of diabetes is steadily increasing in Jammu and Kashmir. According to health studies, diabetes prevalence is estimated at around 18.9 per cent in the Jammu region and 7.8 per cent in Kashmir. A significant number of people are also living with pre-diabetes, increasing the risk of future health complications.
Health experts say the cost of long-term medication remains a major challenge for many families. Surveys have shown that households with diabetic patients often face substantial out-of-pocket healthcare expenses, with some being pushed into financial distress due to the cost of medicines and treatment.
Apart from diabetes drugs, the revised pricing also covers medicines used for high blood pressure and cardiovascular diseases, as well as commonly prescribed nutritional supplements such as Vitamin D3 and calcium.
Officials said the revised prices are expected to be implemented in the market over the next three months, allowing consumers to purchase these medicines at lower rates.
The NPPA, which functions under the Ministry of Chemicals and Fertilisers, said the measure is aimed at improving access to essential medicines and reducing the financial burden on patients who require regular treatment.
The notified prices are exclusive of Goods and Services Tax (GST).
Patients and healthcare stakeholders have welcomed the decision, saying it will provide much-needed relief to families managing chronic diseases and recurring medical expenses.
